Oxera, Edge Health, and Dr Kit Yates have been commissioned by Virgin Atlantic, IAG, TUI, Heathrow, MAG, Collinson, Airlines UK and IATA to undertake an independent review of real-world evidence on the effectiveness of testing schemes for international travellers. Our review focuses on four case studies in different jurisdictions where testing regimes are in place and for which data is available, as follows: Jersey, Canada (Toronto-Pearson Airport), France (Paris-Charles de Gaulle Airport) and Iceland.
This paper follows our report on the review of the effectiveness of testing on arrival schemes, which considered the Public Health England (PHE), London School of Hygiene & Tropical Medicine (LSHTM), and Animal and Plant Health Agency (APHA) papers. Following this paper, we will be updating the modelling completed to date with more recent data that can be aligned with the real-world evidence discussed in this note. The outputs of our analysis are intended to feed into the work of the recently established Global Travel Taskforce as it considers how a testing regime for international arrivals could be implemented to boost safe travel to and from the UK.